Evaluation of HLA-G immune checkpoint molecule in melanocytic lesions

ABSTRACT The human leukocyte antigen-G (HLA-G) is a non-classical molecule of the major histocompatibility complex. HLA-G has been associated with the process of tumorigenesis and tumor escape. In this study, we aim to evaluate the HLA-G expression in melanocytic lesions and in melanoma for determining when melanocytic lesions start its expression. Twenty-two skin biopsies samples were submitted to immunohistochemistry; HLA-G expression was detected in 63.6% of the samples. This expression in melanocytic cells was significantly higher in melanoma than in benign melanocytic lesions (p < 0.002). Our results suggest that HLA-G expression starts late in the process of tumorigenesis.

Saved in:
Bibliographic Details
Main Authors: Gomes,Raylane P, Caetano,Gabriela Tayrine, Sampaio,Lucas Henrique F, Silva,Camila R, Costa,Maurício B, Cysneiro,Maria Auxiliadora, Wastowski,Isabela Jubé
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Patologia Clínica 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442020000100600
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1676-24442020000100600
record_format ojs
spelling oai:scielo:S1676-244420200001006002020-05-06Evaluation of HLA-G immune checkpoint molecule in melanocytic lesionsGomes,Raylane PCaetano,Gabriela TayrineSampaio,Lucas Henrique FSilva,Camila RCosta,Maurício BCysneiro,Maria AuxiliadoraWastowski,Isabela Jubé melanoma HLA-G antigens immunohistochemistry ABSTRACT The human leukocyte antigen-G (HLA-G) is a non-classical molecule of the major histocompatibility complex. HLA-G has been associated with the process of tumorigenesis and tumor escape. In this study, we aim to evaluate the HLA-G expression in melanocytic lesions and in melanoma for determining when melanocytic lesions start its expression. Twenty-two skin biopsies samples were submitted to immunohistochemistry; HLA-G expression was detected in 63.6% of the samples. This expression in melanocytic cells was significantly higher in melanoma than in benign melanocytic lesions (p < 0.002). Our results suggest that HLA-G expression starts late in the process of tumorigenesis.info:eu-repo/semantics/openAccessSociedade Brasileira de Patologia Clínica Jornal Brasileiro de Patologia e Medicina Laboratorial v.56 20202020-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442020000100600en10.5935/1676-2444.20200016
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Gomes,Raylane P
Caetano,Gabriela Tayrine
Sampaio,Lucas Henrique F
Silva,Camila R
Costa,Maurício B
Cysneiro,Maria Auxiliadora
Wastowski,Isabela Jubé
spellingShingle Gomes,Raylane P
Caetano,Gabriela Tayrine
Sampaio,Lucas Henrique F
Silva,Camila R
Costa,Maurício B
Cysneiro,Maria Auxiliadora
Wastowski,Isabela Jubé
Evaluation of HLA-G immune checkpoint molecule in melanocytic lesions
author_facet Gomes,Raylane P
Caetano,Gabriela Tayrine
Sampaio,Lucas Henrique F
Silva,Camila R
Costa,Maurício B
Cysneiro,Maria Auxiliadora
Wastowski,Isabela Jubé
author_sort Gomes,Raylane P
title Evaluation of HLA-G immune checkpoint molecule in melanocytic lesions
title_short Evaluation of HLA-G immune checkpoint molecule in melanocytic lesions
title_full Evaluation of HLA-G immune checkpoint molecule in melanocytic lesions
title_fullStr Evaluation of HLA-G immune checkpoint molecule in melanocytic lesions
title_full_unstemmed Evaluation of HLA-G immune checkpoint molecule in melanocytic lesions
title_sort evaluation of hla-g immune checkpoint molecule in melanocytic lesions
description ABSTRACT The human leukocyte antigen-G (HLA-G) is a non-classical molecule of the major histocompatibility complex. HLA-G has been associated with the process of tumorigenesis and tumor escape. In this study, we aim to evaluate the HLA-G expression in melanocytic lesions and in melanoma for determining when melanocytic lesions start its expression. Twenty-two skin biopsies samples were submitted to immunohistochemistry; HLA-G expression was detected in 63.6% of the samples. This expression in melanocytic cells was significantly higher in melanoma than in benign melanocytic lesions (p < 0.002). Our results suggest that HLA-G expression starts late in the process of tumorigenesis.
publisher Sociedade Brasileira de Patologia Clínica
publishDate 2020
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442020000100600
work_keys_str_mv AT gomesraylanep evaluationofhlagimmunecheckpointmoleculeinmelanocyticlesions
AT caetanogabrielatayrine evaluationofhlagimmunecheckpointmoleculeinmelanocyticlesions
AT sampaiolucashenriquef evaluationofhlagimmunecheckpointmoleculeinmelanocyticlesions
AT silvacamilar evaluationofhlagimmunecheckpointmoleculeinmelanocyticlesions
AT costamauriciob evaluationofhlagimmunecheckpointmoleculeinmelanocyticlesions
AT cysneiromariaauxiliadora evaluationofhlagimmunecheckpointmoleculeinmelanocyticlesions
AT wastowskiisabelajube evaluationofhlagimmunecheckpointmoleculeinmelanocyticlesions
_version_ 1756427560003043328